It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Lumos Diagnostics Holdings Limited's (ASX:LDX) case, it's fantastic news ...

Lumos Diagnostics is striving to become the leader in simple point-of-care tests to distinguish between viral and bacterial ...

Spartanburg residents have filed a lawsuit against Lumos Fiber of South Carolina, a fiber-optic internet service provider, ...

Lumos, the industry's first Autonomous Identity Platform, has launched new capabilities that enable IT and security teams to ...

T-Mobile outlined plans to explore further M&A opportunities around its fiber offering. The carrier has made fiber a big ...

Securing reimbursement is a crucial step towards widespread adoption of FebriDx in the U.S. Lumos aims to demonstrate the test’s clear clinical benefit, its impact on improving diagnostic efficiency, ...

AI-powered platform ensures the right people and AI agents have the right access for the right time — reducing security risks, unlocking productivity, and driving profitability Lumos' new ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Lumos is commercialising its FDA-approved Febridx test to distinguish between viral and bacterial ...